A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 1)
- Sponsor:
- Incyte Corp.
- Sponsor Study ID:
- NCB123667-203
- CTO #:
- 104246
- NCT Number:
- NCT07023627
- Phase:
- II
- Protocol Type:
- Treatment
- Age Group:
- Adults
- Disease Sites:
- Ovary
- Study Objectives:
- To evaluate the efficacy of INCB123667 monotherapy in participants with PROC with cyclin E1 overexpression (Cohort 1).
- eConsent:
- Not available
- Study Documents:
-
Open Study Documents
(MUSC NetID required for document access)
For more information about this trial please contact the study team:
-
Medical University of South Carolina
- Principal Investigator, Orr, Brian, at orrb@musc.edu
- Study Coordinator, Knox, Crystal, at knoxc@musc.edu
Trial opened at the following institutions:
Medical University of South Carolina